Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Flow Chemistry. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Avoid heavy metal catalysts and anhydrous conditions in pyrido[1,2-a][1,3,5]-triazin-4-one synthesis. Reduce production costs and supply chain risks with this scalable, high-yield method.
Solve high-cost, low-yield issues in tegrazan intermediate production. New route achieves ≥99% purity with simplified steps and 100kgs+ scale capability.
Discover how metal-free, photo-catalyzed synthesis of perfluoroalkyl benzimidazoloisoquinolinones reduces costs and supply chain risks for pharmaceutical intermediates. Contact us for custom synthesis.
Solve chiral ligand supply chain risks with this metal-free synthesis. 86% yield, no resolution needed. Contact for custom production.
Discover how electrochemical catalysis eliminates metal catalysts and harsh conditions in benzyl alcohol production, reducing costs and supply chain risks for pharmaceutical intermediates. Contact us for scalable solutions.
Solve supply chain risks with metal-free, high-yield synthesis of trifluoromethyl selenium azaspiro[4,5]-tetraenone. Reduce costs and ensure 99% purity for pharma R&D and production.
Overcome chiral resolution challenges in Niraparib manufacturing. New metal-free synthesis achieves 97.51% purity with 26.75% overall yield. Reduce equipment costs and supply chain risks.
Eliminate expensive catalysts and harsh conditions in aryltrimethylstannane production. 95% yields, metal-free process, and scalable manufacturing for pharmaceutical intermediates.
Solve ASC-J9 supply chain challenges with 95% yield, 98.6% purity, and 3h reaction time. CDMO expertise for pharma scale.
Solve metal residue issues in 3-thioindole production with metal-free photocatalysis. Achieve 70% yield, simplified process, and GMP compliance for your drug development projects.
Overcome riociguat synthesis challenges: 40% yield, <0.05% impurity, and DMF-free process. NINGBO INNO PHARMCHEM delivers GMP-compliant production for your API needs.
Solve asymmetric synthesis challenges with novel chiral nitrogen-diene ligands. 99% yield, 90% ee, and water-tolerant processes reduce production costs for pharma R&D and manufacturing.
Solve asymmetric synthesis challenges with novel chiral nitrogen-diene ligands. 99% yield, 90% ee in rhodium-catalyzed reactions. Scale to 100 MT/annual with NINGBO INNO PHARMCHEM.
Discover how this novel alkylation method reduces production costs by 30% and eliminates hazardous reagents for agrochemical manufacturing.
Solve supply chain risks with this metal-free, high-yield synthesis method for pharmaceutical intermediates. Eliminate heavy metal catalysts and reduce production costs by 30%.
Solve supply chain risks with 85-93% yield 2-hydroxyphenyl sulfide synthesis. CDMO expertise in metal-free catalysis for API manufacturing.
Solve nitrile synthesis challenges with this novel metal-free route. Achieve 78% yield, no toxic byproducts, and scalable production for anti-inflammatory drug development.
Solve low-yield issues in coumarin synthesis with 97%+ yields. Our CDMO expertise scales this patent-protected method for stable API supply chains.
Discover how metal-free photoredox catalysis enables high-yield, enantioselective synthesis of chiral thiochroman-4-ketones for anticancer drug development. Reduce supply chain risks and GMP compliance costs.
Discover how symmetric bispiperidine metal complexes solve multi-step synthesis challenges in API manufacturing with >99% selectivity and reduced supply chain risks for pharma R&D and production teams.